Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade.
NAVPS (12-24-2024) |
$9.19 |
---|---|
Change |
$0.03
(0.28%)
|
As at November 30, 2024
As at November 30, 2024
As at July 31, 2024
Inception Return (April 11, 2017): 0.32%
Row Heading | Return | Annualized Return | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
Fund | -12.36% | -9.19% | -18.02% | -11.87% | -11.49% | -15.96% | -19.78% | -16.13% | -8.36% | -8.89% | -2.40% | - | - | - |
Benchmark | 6.37% | 10.66% | 16.91% | 25.77% | 30.69% | 15.61% | 10.90% | 13.91% | 11.92% | 12.54% | 10.25% | 10.17% | 10.75% | 8.96% |
Category Average | 4.46% | 5.21% | 11.24% | 21.90% | 26.75% | 20.45% | 5.39% | 8.61% | 11.96% | 12.20% | 11.37% | 12.77% | 11.28% | 11.60% |
Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Return % | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | 0.43% | 14.71% | -0.39% | 7.93% | 4.27% | -16.39% | -2.29% | 1.31% | -8.81% | 6.29% | -2.50% | -12.36% |
Benchmark | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% | 6.37% |
23.11% (August 2018)
-16.39% (May 2024)
Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | 16.79% | -6.72% | 37.72% | -6.06% | -37.61% | -6.09% |
Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
Category Rank | - | - | - | - | - | - | - | - | - | - |
37.72% (2020)
-37.61% (2022)
Name | Percent |
---|---|
US Equity | 67.59 |
Cash and Equivalents | 20.58 |
Canadian Equity | 11.80 |
Derivatives | 0.07 |
International Equity | -0.02 |
Other | -0.02 |
Name | Percent |
---|---|
Healthcare | 47.76 |
Cash and Cash Equivalent | 20.58 |
Consumer Services | 20.40 |
Consumer Goods | 6.73 |
Technology | 3.68 |
Other | 0.85 |
Name | Percent |
---|---|
North America | 100.04 |
Europe | -0.02 |
Other | -0.02 |
Name | Percent |
---|---|
Green Thumb Industries Inc | 19.03 |
United States Dollar | 15.88 |
Costco Wholesale Corp | 14.39 |
Trulieve Cannabis Corp | 9.26 |
Cresco Labs Inc | 4.25 |
Terrascend Corp | 4.03 |
Johnson & Johnson | 3.43 |
Walmart Inc | 3.00 |
Procter & Gamble Co | 2.95 |
Canadian Dollar | 2.37 |
Ninepoint Cannabis and Alternative Health Fund Series A
Median
Other - Sector Equity
Standard Deviation | 25.13% | 25.79% | - |
---|---|---|---|
Beta | 0.65% | 0.68% | - |
Alpha | -0.26% | -0.14% | - |
Rsquared | 0.13% | 0.18% | - |
Sharpe | -0.89% | -0.30% | - |
Sortino | -1.01% | -0.45% | - |
Treynor | -0.34% | -0.11% | - |
Tax Efficiency | - | - | - |
Volatility | - |
Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
---|---|---|---|---|
Standard Deviation | 30.35% | 25.13% | 25.79% | - |
Beta | -0.74% | 0.65% | 0.68% | - |
Alpha | 0.12% | -0.26% | -0.14% | - |
Rsquared | 0.05% | 0.13% | 0.18% | - |
Sharpe | -0.41% | -0.89% | -0.30% | - |
Sortino | -0.47% | -1.01% | -0.45% | - |
Treynor | 0.17% | -0.34% | -0.11% | - |
Tax Efficiency | - | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Start Date | April 11, 2017 |
---|---|
Instrument Type | Mutual Fund |
Share Class | Do-It-Yourself |
Legal Status | Trust |
Sales Status | Open |
Currency | CAD |
Distribution Frequency | Annual |
Assets ($mil) | - |
FundServ Code | Load Code | Sales Status |
---|---|---|
NPP5420 |
The Fund’s objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions.
The Fund will primarily invest in a portfolio of companies that are listed on North American exchanges that have a business strategy focused on new and alternative health and wellness related themes that are growing in acceptance and importance in North America.
Name | Start Date |
---|---|
Douglas Waterson | 03-26-2017 |
Charles Taerk | 03-26-2017 |
Ninepoint Partners LP | 08-01-2017 |
Fund Manager | Ninepoint Partners LP |
---|---|
Advisor | Ninepoint Partners LP |
Custodian | CIBC Mellon Trust Company |
Registrar | CIBC Mellon Trust Company |
Distributor | - |
Auditor | KPMG LLP |
RSP Eligible | Yes |
---|---|
PAC Allowed | Yes |
PAC Initial Investment | 1,000 |
PAC Subsequent | 100 |
SWP Allowed | Yes |
SWP Min Balance | 0 |
SWP Min Withdrawal | 0 |
MER | 3.43% |
---|---|
Management Fee | 2.25% |
Load | Back Fee Only |
FE Max | 5.00% |
DSC Max | - |
Trailer Fee Max (FE) | 1.00% |
Trailer Fee Max (DSC) | - |
Trailer Fee Max (NL) | - |
Trailer Fee Max (LL) | - |
Join Fund Library now and get free access to personalized features to help you manage your investments.